文献速递肝病

轻度腹水对肝硬化患者预后的意义

Prognostic significance of mild ascites in patients with cirrhosis.
PubMed 文献 · Hepatology · 2025-07-03

这项回顾性队列研究利用VOCAL队列分析41699例肝硬化患者,按影像学腹水程度分为无腹水、G1轻度腹水和G2/G3显性腹水三组。中位随访7.7年,G1腹水中位生存3.9年,低于无腹水的6.5年、高于G2/G3腹水的3.5年;校正混杂后G1腹水死亡风险HR为1.50,G2/G3为1.63。

要点

  • G1轻度腹水中位生存3.9年,低于无腹水6.5年、高于G2/G3腹水3.5年。
  • 校正混杂后G1腹水死亡风险HR 1.50(95%CI 1.44-1.57,p<0.001)。
  • G1腹水代表介于代偿期与失代偿期肝硬化之间的中间预后阶段。

核心结论

  • G1(轻度或亚临床)腹水与较无腹水更差的生存相关,代表代偿期与失代偿期肝硬化之间的中间预后阶段。

研究设计与样本

  • 回顾性队列研究,使用退伍军人肝病结局与费用(VOCAL)队列的肝硬化患者。
  • 采用自然语言处理分析肝硬化诊断时的影像报告,将患者分为无腹水、G1(轻度)腹水和G2/G3(显性)腹水三组。
  • 共纳入41699例患者:无腹水28628例(68.7%),G1腹水4046例(9.7%),G2/G3腹水6268例(15.0%)。
  • 中位随访时间7.7年(IQR 5.1-10.6)。

主要发现

  • G1腹水中位生存3.9年(IQR 1.8-8.3),显著低于无腹水者的6.5年(IQR 3.1-12.2,p<0.0001)。
  • G1腹水中位生存3.9年(IQR 1.8-8.3),显著高于G2/G3腹水者的3.5年(IQR 1.5-7.9,p<0.0001)。
  • 校正潜在混杂因素后,任何级别腹水均与更高的死亡风险相关:G1腹水HR 1.50(95%CI 1.44-1.57,p<0.001),G2/G3腹水HR 1.63(95%CI 1.57-1.69,p<0.001)。
  • 上述结果在多项敏感性分析中保持一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Overt (clinically detectable) ascites is the most common decompensating event in cirrhosis and is associated with a high mortality. The impact of mild ascites (only detectable by imaging) remains unclear. APPROACH AND RESULTS: Retrospective cohort study in patients with cirrhosis using the Veterans Outcomes and Costs Associated with Liver Disease (VOCAL) cohort. Imaging reports at the time of diagnosis of cirrhosis were analyzed using natural language processing and classified into 3 groups: no ascites, grade 1 (G1) or mild ascites, and grade 2/3 (G2/G3) or overt ascites. Mortality was compared across the groups using the Kaplan-Meier method and multivariable Cox proportional hazards analysis. A total of 41,699 patients were included in the study: 28,628 (68.7%) without ascites, 4046 (9.7%) with G1, and 6268 (15.0%) with G2/G3 ascites. Median follow-up time was 7.7 years (IQR 5.1-10.6). In patients with G1 (mild) ascites, median survival was 3.9 years (IQR 1.8-8.3), significantly lower than in those without ascites (6.5 years; IQR 3.1-12.2, p <0.0001) but significantly higher than in those with G2/G3 ascites (3.5 years; IQR 1.5-7.9, p <0.0001). After adjusting for potential confounders, the presence of any grade of ascites was associated with a higher hazard of mortality: G1 ascites (HR 1.50; 95% CI 1.44-1.57, p <0.001) and G2/G3 ascites (HR 1.63; 95% CI 1.57-1.69, p <0.001). These results were consistent across multiple sensitivity analyses. CONCLUSIONS: Grade 1 (mild or subclinical) ascites is associated with poorer survival compared with no ascites and represents an intermediate prognostic stage between compensated and decompensated cirrhosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Chong Lugon N, Rabiee A, Mezzacappa C, et al. Prognostic significance of mild ascites in patients with cirrhosis. Hepatology. 2025. PMID: 40607762. doi:10.1097/HEP.0000000000001452

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。